Mariana Lenharo in Nature:
Artificial intelligence (AI) already helps clinicians to make diagnoses, triage critical cases and transcribe clinical notes in hospitals across the United States. But regulation of medical AI products has not kept up with the rapid pace of their adoption, argue researchers in a report published on 5 June in PLOS Digital Health1. The authors point to limitations in how the US Food and Drug Administration (FDA) approves these devices, and propose broader strategies that extend beyond the agency to help ensure that medical AI tools are safe and effective.
More than 1,000 medical AI products have been cleared by the FDA, and hospitals are rapidly adopting them. Unlike most other FDA-regulated products, AI tools continue to evolve after approval as they are updated or retrained on new data. This raises the need for continuous oversight, which current regulations have limited capacity to ensure.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.

At midcentury, Marianne Moore emerged as a public personage, but not before a painful period of loss. Prefaced by a host of personal disasters—the death of her mother’s onetime partner Mary Norcross, her own hospitalization for digestive problems, her mother’s painful shingles and neuralgia—the decade of the 1940s brought sorrow. Moore had to deal with the rejection of her only attempt at a novel and the news that her Selected Poems had been remaindered at thirty cents a copy. Bouts of bursitis and bronchitis prompted her to hire a succession of nurses and helpers, one of whom—Gladys Berry—would work for Moore into her old age.
WHEN MARCEL DUCHAMP mounted a challenge to Constantin Brancusi during a joint visit to an exhibition of new airplane technologies in Paris in 1912—asking Brancusi whether he could ever sculpt anything as perfect as an airplane propeller—he figured a contradiction that haunted sculptural production for the remaining part of the twentieth century and into the first two decades of the twenty-first: the dialectics between traditional artisanal and artistic modes of sculptural production and the ever more compelling paradigm of the technologically produced readymade. Obviously, this dialectic has been constitutive of Gabriel Orozco’s work from the very beginning and determines it to this very day.
Dear Reader,
In December 2013, not long after the publication of Mike Tyson’s autobiography, The Wall Street Journal asked him—along with forty‑nine other distinguished writers, academics, artists, politicians, and CEOs—to name their favorite books of the year. Among Tyson’s selections was a Kindle book, 
T
Two weeks ago, in the run-up to the release of her ninth studio album, “Something Beautiful,” Miley Cyrus, who is thirty-two and one of the most successful pop stars of all time, revealed, in an
I found the doorknobs
D
J
Eight times a week at the Majestic Theater in Manhattan, the entire, harrowing arc of a classic tragedy is delivered in 4½ minutes that are as exhilarating as they are upsetting. All the textbook components of tragedy according to Aristotle are vigorously at work here: self-delusion and self-knowledge, pity and terror, and the sense that what is happening is somehow both unexpected and inevitable.